Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial
围手术期托瑞普利单抗联合新辅助化疗可能改善可切除食管癌的预后:一项 III 期随机临床试验的中期分析
期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12604
Zheng, Yan; Liang, Guanghui; Yuan, Dongfeng; Liu, Xianben; Ba, Yufeng; Qin, Zimin; Shen, Sining; Li, Zhenxuan; Sun, Haibo; Liu, Baoxing; Gao, Quanli; Li, Peng; Wang, Zongfei; Liu, Shilei; Zhu, Jianping; Wang, Haoran; Ma, Haibo; Liu, Zhenzhen; Zhao, Fei; Zhang, Jun; Zhang, He; Wu, Daoyuan; Qu, Jinrong; Ma, Jie; Zhang, Peng; Ma, Wenjie; Yan, Ming; Yu, Yongkui; Li, Qing; Zhang, Jiangong; Xing, Wenqun